甲狀腺結節是一種常見的疾病，影響多達60 ％的人口。估計發生甲狀腺結節的終生概率為10 ％。雖然大多數甲狀腺結節是良性的，但高達10-15%的結節會擴大，導致壓迫性症狀，包括頸部壓力和不適、吞咽困難、呼吸困難和發音困難。這些良性但有問題的結節的傳統治療方法是甲狀腺切除術。
適應症：Thyroid Nodule \(Benign\)、Ablation Therapy
收案條件
納入條件
- Adult patients \>/=18 years of age
- Nodule maximal diameter ≥2cm and nodule volume \<20ml
- Nodule being predominantly solid (≥80% solid)
- Confirmed benign nature of nodules, either by : two benign fine needle biopsies, with the most recent biopsy performed within 1 year of enrollment in study or one benign fine needle biopsy and low suspicion characteristics on ultrasound
- Both functional and non-functional nodules are eligible.
排除條件
- Cytologically indeterminate nodules
- Nodules with substernal extension or posterior extension that cannot be viewed sufficiently with ultrasound
- current pregnancy or cardiac arrhythmias; presence of pacemaker or any medical condition that renders patient unfit for thermal ablation
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。